[
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More",
    "summary": "Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts adjusted earnings below expectations.",
    "url": "https://finnhub.io/api/news?id=8ec491052b15ab4e30d1564bf33829ba82a9d8d89da05a71d2e280d93fdfecc0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738358220,
      "headline": "These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More",
      "id": 132631712,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts adjusted earnings below expectations.",
      "url": "https://finnhub.io/api/news?id=8ec491052b15ab4e30d1564bf33829ba82a9d8d89da05a71d2e280d93fdfecc0"
    }
  },
  {
    "ts": null,
    "headline": "How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter",
    "summary": "Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.",
    "url": "https://finnhub.io/api/news?id=2b5abdb4971c9a11192cea64ce74d24687773625f6caff8589edb139f0f00bf5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738357899,
      "headline": "How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter",
      "id": 132631713,
      "image": "https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.",
      "url": "https://finnhub.io/api/news?id=2b5abdb4971c9a11192cea64ce74d24687773625f6caff8589edb139f0f00bf5"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute",
    "summary": "Yahoo Finance host Josh Lipton breaks down the day's top trending stocks and market stories in the Market Minute. AbbVie (ABBV) shares continue to pop in Friday trading after raising its revenue guidance for new drugs Skyrizi and Rinvoq. Vertex Pharmaceuticals (VRTX) stock is rising after receiving approval by the Food and Drug Administration (FDA) over its new non-opioid pain management drug, Journavx. Lastly, oil giants Exxon Mobil (XOM) and Chevron (CVX) move lower as the industry is monitoring the long-term impacts of President Trump's tariffs. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. This post was written by Luke Carberry Mogan.",
    "url": "https://finnhub.io/api/news?id=684bc6bb1933c00be14cde32b294316d46713d92779f31132e9cd989f88f3c84",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738343816,
      "headline": "AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute",
      "id": 132631714,
      "image": "https://s.yimg.com/ny/api/res/1.2/RPPJBnd.GjIkjnTLlYYJ0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/os/creatr-uploaded-images/2025-01/21b4fc00-dff7-11ef-bf3d-13a482249c9b",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Josh Lipton breaks down the day's top trending stocks and market stories in the Market Minute. AbbVie (ABBV) shares continue to pop in Friday trading after raising its revenue guidance for new drugs Skyrizi and Rinvoq. Vertex Pharmaceuticals (VRTX) stock is rising after receiving approval by the Food and Drug Administration (FDA) over its new non-opioid pain management drug, Journavx. Lastly, oil giants Exxon Mobil (XOM) and Chevron (CVX) move lower as the industry is monitoring the long-term impacts of President Trump's tariffs. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. This post was written by Luke Carberry Mogan.",
      "url": "https://finnhub.io/api/news?id=684bc6bb1933c00be14cde32b294316d46713d92779f31132e9cd989f88f3c84"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug",
    "summary": "Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.",
    "url": "https://finnhub.io/api/news?id=b7b6893bd26006818b68ec07a5dd796182e6a4db983de36d10c05ad7bcab128a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738331419,
      "headline": "Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug",
      "id": 132506039,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1635084121/image_1635084121.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.",
      "url": "https://finnhub.io/api/news?id=b7b6893bd26006818b68ec07a5dd796182e6a4db983de36d10c05ad7bcab128a"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller",
    "summary": "Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller",
    "url": "https://finnhub.io/api/news?id=abc9d0c48ec48d78d5024ba1532cac0b8cb962da548d9b36ed322d4e7cec32ce",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738321020,
      "headline": "Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller",
      "id": 134149238,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller",
      "url": "https://finnhub.io/api/news?id=abc9d0c48ec48d78d5024ba1532cac0b8cb962da548d9b36ed322d4e7cec32ce"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller",
    "summary": "Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller",
    "url": "https://finnhub.io/api/news?id=bd18e30013bd3f250817d274542ab5403914477f797be823620784c95d14d368",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738316850,
      "headline": "Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller",
      "id": 132524575,
      "image": "",
      "related": "VRTX",
      "source": "DowJones",
      "summary": "Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller",
      "url": "https://finnhub.io/api/news?id=bd18e30013bd3f250817d274542ab5403914477f797be823620784c95d14d368"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Announces FDA Approval of JOURNAVX, a First-in-Class Treatment for Adults with Moderate-to-Severe Acute Pain",
    "summary": "BOSTON - Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has approved JOURNAVX , an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for...",
    "url": "https://finnhub.io/api/news?id=3eb4adf72bf3dfa6294a2b8e348b71fe5c5598955b7bbb45ed7732b4313ce03d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738305252,
      "headline": "Vertex Announces FDA Approval of JOURNAVX, a First-in-Class Treatment for Adults with Moderate-to-Severe Acute Pain",
      "id": 132504014,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "BOSTON - Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has approved JOURNAVX , an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for...",
      "url": "https://finnhub.io/api/news?id=3eb4adf72bf3dfa6294a2b8e348b71fe5c5598955b7bbb45ed7732b4313ce03d"
    }
  },
  {
    "ts": null,
    "headline": "FDA approves painkiller designed to eliminate the risk of addiction associated with opioids",
    "summary": "WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin....",
    "url": "https://finnhub.io/api/news?id=a0b59e6a8271dac40d6b868498225514f9f6e5ba3c362f3bb919bc68d4f0c3d9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738300033,
      "headline": "FDA approves painkiller designed to eliminate the risk of addiction associated with opioids",
      "id": 132503590,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin....",
      "url": "https://finnhub.io/api/news?id=a0b59e6a8271dac40d6b868498225514f9f6e5ba3c362f3bb919bc68d4f0c3d9"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.",
    "summary": "Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.",
    "url": "https://finnhub.io/api/news?id=72bcbae22c093bd52d6efdc47f209a6218da523ab9c45966c436ec895299af26",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738298100,
      "headline": "Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.",
      "id": 132524595,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.",
      "url": "https://finnhub.io/api/news?id=72bcbae22c093bd52d6efdc47f209a6218da523ab9c45966c436ec895299af26"
    }
  }
]